Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

被引：0
|
作者：
Ito, Shun [1 ]
Banno, Masahiro [2 ,3 ,4 ]
Okazaki, Yuji [4 ,5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, 2-17-77,Higashinaniwa Cho, Amagasaki, Hyogo 6608550, Japan
[2] Seichiryo Hosp, Dept Psychiat, 4-16-27,Tsurumai,Showa Ku, Nagoya, Aichi 4660064, Japan
[3] Nagoya Univ, Dept Psychiat,, Grad Sch Med, 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668560, Japan
[4] Sci Res WorkS Peer Support Grp SRWS PSG, Osaka, Japan
[5] Hiroshima City Hiroshima Citizens Hosp, Dept Emergency Med, 7-33 Motomachi,Naka Ku, Hiroshima, Hiroshima 7308518, Japan
来源：
INFECTIOUS DISEASES AND THERAPY | 2023年 / 12卷 / 01期
关键词：
D O I：
10.1007/s40121-022-00728-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
    Evgeny Bazdyrev
    Maria Panova
    Maria Brachs
    Elena Smolyarchuk
    Daria Tsygankova
    Liudmila Gofman
    Yana Abdyusheva
    Fedor Novikov
    Journal of Translational Medicine, 20
  • [22] Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials"
    Huang, Po-Yu
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Tsai, Ya-Wen
    Lai, Chih-Cheng
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (07)
  • [23] Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study
    Saib, Anis
    Amara, Walid
    Wang, Pascal
    Cattan, Simon
    Dellal, Azeddine
    Regaieg, Kais
    Nahon, Stephane
    Nallet, Olivier
    Nguyen, Lee S.
    PLOS ONE, 2021, 16 (06):
  • [24] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
    Juan P. Horcajada
    Rebeca Aldonza
    Mónica Real
    Silvia Castañeda-Espinosa
    Elena Sendra
    Joan Gomez-Junyent
    Inmaculada López-Montesinos
    Silvia Gómez-Zorrilla
    Silvia Briansó
    Montserrat Duran-Taberna
    Andrés Fernández
    Cristina Tarragó
    Teresa Auguet-Quintillá
    Pneumonia, 16
  • [25] Enpatoran in COVID-19 pneumonia: Safety and efficacy results from a phase II randomized trial
    Mckinnon, John E.
    Santiaguel, Joel
    de Oliveira, Claudia Murta
    Yu, Dongzi
    Khursheed, Mukhy
    Moreau, Flavie
    Klopp-Schulze, Lena
    Shaw, Jamie
    Roy, Sanjeev
    Kao, Amy H.
    ANEMONE Study Team
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2640 - 2653
  • [26] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
    Horcajada, Juan P.
    Aldonza, Rebeca
    Real, Monica
    Castaneda-Espinosa, Silvia
    Sendra, Elena
    Gomez-Junyent, Joan
    Lopez-Montesinos, Inmaculada
    Gomez-Zorrilla, Silvia
    Brianso, Silvia
    Duran-Taberna, Montserrat
    Fernandez, Andres
    Tarrago, Cristina
    Auguet-Quintilla, Teresa
    PNEUMONIA, 2024, 16 (01)
  • [27] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Firozabad, Amirreza Roostaei
    Meybodi, Zohreh Akhoundi
    Mousavinasab, Seyed Ruhollah
    Sahebnasagh, Adeleh
    Jelodar, Mohsen Gholinataj
    Karimzadeh, Iman
    Habtemariam, Solomon
    Saghafi, Fatemeh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [28] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Amirreza Roostaei Firozabad
    Zohreh Akhoundi Meybodi
    Seyed Ruhollah Mousavinasab
    Adeleh Sahebnasagh
    Mohsen Gholinataj Jelodar
    Iman Karimzadeh
    Solomon Habtemariam
    Fatemeh Saghafi
    BMC Infectious Diseases, 21
  • [29] Efficacy and Safety of Therapeutic Versus Prophylactic Dose of Anticoagulation in Hospitalized Patients with Severe COVID-19 Pneumonia and Coagulopathy: An Open-Label, Randomized Controlled Trial
    Adrian, L. H.
    Hutomo, S. A.
    Negari, A. D. S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [30] METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2
    Hamidi-Alamdari, Daryoush
    Hafizi-Lotfabadi, Saied
    Bagheri-Moghaddam, Ahmad
    Safari, Hossin
    Mozdourian, Mahnaz
    Javidarabshahi, Zahra
    Peivandi-Yazdi, Arash
    Ali-Zeraati, Abass
    Sedaghat, Alireza
    Poursadegh, Farid
    Barazandeh-Ahmadabadi, Fatemeh
    Agheli-Rad, Marzieh
    Tavousi, Seyed M.
    Vojouhi, Shohreh
    Amini, Shahram
    Amini, Mahnaz
    Majid-Hosseini, Seyed
    Tavanaee-Sani, Ashraf
    Ghiabi, Amin
    Nabavi-Mahalli, Shima
    Morovatdar, Negar
    Rajabi, Omid
    Koliakos, George
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (03): : 190 - 198
12345